ZFP192 inhibitors are a class of chemical compounds designed to target zinc finger protein 192 (ZFP192), a transcription factor that regulates gene expression by binding to specific DNA sequences. ZFP192, like other zinc finger proteins, contains zinc finger motifs, which are structural domains that enable the protein to recognize and bind to particular DNA regions. These motifs are stabilized by zinc ions, which are critical for maintaining the protein's three-dimensional conformation necessary for DNA binding. ZFP192 plays an essential role in controlling the transcription of various genes, influencing a wide range of cellular processes. Inhibitors of ZFP192 act by disrupting its interaction with DNA, either by destabilizing the zinc finger motifs or by blocking the protein's ability to bind to its target sequences, resulting in altered gene expression.
The mechanisms through which ZFP192 inhibitors function can differ depending on their chemical structure. One common mechanism is the chelation of zinc ions, which are vital for maintaining the structural integrity of the zinc finger domains. By binding to or sequestering these zinc ions, the inhibitors cause the zinc finger motifs to lose their proper shape, preventing ZFP192 from binding to DNA and carrying out its regulatory functions. Other inhibitors may interfere with protein-protein interactions necessary for ZFP192 to form transcriptional complexes, further impairing its ability to regulate gene expression. By disrupting these interactions, ZFP192 inhibitors can alter the transcriptional activity of genes under its control. The study of ZFP192 inhibitors provides valuable insights into the broader role of zinc finger proteins in transcriptional regulation, highlighting their importance in modulating gene networks and maintaining cellular function.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits RNA synthesis by intercalating into DNA, leading to the prevention of transcription, potentially impacting ZKSCAN8 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide inhibits topoisomerase II, which can lead to DNA damage and subsequently affect transcription, potentially impacting the expression of ZKSCAN8. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A inhibits calcineurin, a phosphatase involved in the activation of T cells. It may indirectly influence ZKSCAN8 expression through immunosuppressive effects. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, potentially impacting chromatin structure and gene expression, including the expression of ZKSCAN8. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Puromycin is an inhibitor of protein synthesis and can impact overall cellular protein levels, potentially including the expression of ZKSCAN8. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor, potentially impacting chromatin structure and gene expression, including the expression of ZKSCAN8. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $270.00 | 5 | |
Bleomycin induces DNA strand breaks and can impact transcription, potentially influencing the expression of ZKSCAN8. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Azacitidine is a DNA methyltransferase inhibitor, potentially impacting DNA methylation patterns and gene expression, including the expression of ZKSCAN8. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C crosslinks DNA, leading to DNA damage and potential effects on transcription, which could impact the expression of ZKSCAN8. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits topoisomerase I, leading to DNA damage and potential effects on transcription, which could impact the expression of ZKSCAN8. |